IDEXX Laboratories Inc IDXX
$676.21 −$13.44 (-1.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $674.72 -0.22%
Open$688.61
Prev close$689.65
Day range$672.72 – $696.89
Volume614.4K
Market cap$53.28B
P/E (TTM)45.6
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.21B+9.9% YoY
Operating profit$402.35M+13.4% YoY
Net profit$317.15M+15.5% YoY
Diluted EPS$4.01+17.9% YoY
Free cash flow$420.79M+17.6% YoY
Operating cash flow$449.72M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin62.7%
Operating margin32.3%
Net margin25.4%
Return on equity68.9%
Return on assets33.3%
Return on invested capital43.8%
Current ratio1.19
Liabilities / assets49.6%
Cash & investments$197.54M
Total debt$946.41M
Net cash (debt)-$748.87M
Free cash flow / sales27.9%
Where the revenue comes from
Quarter 2026/Q3
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-22 05:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $4.30B | Annual | 2025-12-31 | 2026-02-20 |
| Net income | $1.06B | Annual | 2025-12-31 | 2026-02-20 |
| Operating cash flow | $1.18B | Annual | 2025-12-31 | 2026-02-20 |
| Total assets | $3.35B | Period end | 2025-12-31 | 2026-02-20 |
| Total liabilities | $1.75B | Period end | 2025-12-31 | 2026-02-20 |
| Stockholders’ equity | $1.61B | Period end | 2025-12-31 | 2026-02-20 |
| Cash and cash equivalents | $180.07M | Period end | 2025-12-31 | 2026-02-20 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.21B | $1.22B | $1.14B | $4.30B | $1.09B |
| Total Operating Revenue | $1.21B | $1.22B | $1.14B | $4.30B | $1.09B |
| Cost of Revenue | $449.94M | $437.50M | $418.08M | $1.64B | $432.47M |
| Gross Profit | $764.30M | $779.09M | $722.74M | $2.66B | $658.11M |
| Operating Expense | $361.95M | $353.52M | $360.15M | $1.30B | $342.51M |
| Selling and Admin Expenses | $293.13M | $288.09M | $294.37M | $1.05B | $275.68M |
| -Selling & Marketing Expense | $169.85M | $171.28M | $175.25M | $643.55M | $167.06M |
| -General & Admin Expense | $123.28M | $116.82M | $119.12M | $404.79M | $108.62M |
| Research & Development | $68.82M | $65.43M | $65.79M | $251.21M | $66.83M |
| Operating Profit | $402.35M | $425.57M | $362.59M | $1.36B | $315.61M |
| Net Non-Operating Interest Income (Expense) | -$6.49M | -$9.58M | -$7.14M | -$35.84M | -$8.62M |
| Non-Operating Interest Income | $967,000.00 | $606,000.00 | $597,000.00 | $3.01M | $587,000.00 |
| Non-Operating Interest Expense | $7.46M | $10.18M | $7.74M | $38.85M | $9.21M |
| Other Income (Expense) | $3.47M | $1.23M | – | – | – |
| Gain on Sale of Security | $3.47M | $1.23M | – | – | – |
| Pretax Profit | $399.33M | $417.22M | $355.44M | $1.32B | $306.98M |
| Tax | $82.18M | $78.81M | $77.00M | $264.73M | $58.79M |
| Net Profit | $317.15M | $338.41M | $278.45M | $1.06B | $248.19M |
| Profit from Continuing Operations | $317.15M | $338.41M | $278.45M | $1.06B | $248.19M |
| Net Income to Parent Company | $317.15M | $338.41M | $278.45M | $1.06B | $248.19M |
| Net Income to Common Stockholders | $317.15M | $338.41M | $278.45M | $1.06B | $248.19M |
| Basic EPS | $4.02 | $4.29 | $3.50 | $13.17 | $3.11 |
| Diluted EPS | $4.01 | $4.27 | $3.47 | $13.08 | $3.08 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.71B | $3.44B | $3.39B | $3.35B | $3.35B |
| Total Current Assets | $1.50B | $1.51B | $1.45B | $1.41B | $1.41B |
| Cash and Cash Equivalents & Short-Term Investments | $197.54M | $196.93M | $200.53M | $180.07M | $180.07M |
| -Cash and Cash Equivalents | $197.54M | $196.93M | $200.53M | $180.07M | $180.07M |
| Receivables | $721.32M | $741.67M | $697.21M | $693.19M | $693.19M |
| -Accounts Receivable | $615.80M | $627.08M | $603.54M | $552.38M | $552.38M |
| -Taxes Receivable | $19.77M | $32.31M | $15.97M | $64.99M | $64.99M |
| -Other Receivables | $85.75M | $82.28M | $77.70M | $75.83M | $75.83M |
| Prepaid Assets | $67.20M | $61.96M | $64.35M | $57.90M | $57.90M |
| Inventory | $390.87M | $391.58M | $382.40M | $377.76M | $377.76M |
| Other Current Assets | $123.08M | $117.35M | $109.59M | $104.91M | $104.91M |
| Total Non-Current Assets | $2.21B | $1.93B | $1.93B | $1.94B | $1.94B |
| Net PPE | $851.96M | $856.00M | $861.78M | $870.61M | $870.61M |
| -Gross PPE | $851.96M | $856.00M | $861.78M | $1.80B | $1.80B |
| Investments and Advances | $56.01M | $53.94M | $53.59M | $58.48M | $58.48M |
| -Available for Sale Securities | $29.05M | $28.79M | – | – | – |
| Non Current Accounts Receivables | $263.16M | $250.36M | $240.96M | $236.91M | $236.91M |
| Goodwill and Other Intangible Assets | $758.28M | $509.12M | $516.85M | $523.85M | $523.85M |
| -Goodwill | $640.51M | $410.95M | $412.10M | $414.00M | $414.00M |
| -Other Intangible Assets | $117.77M | $98.17M | $104.75M | $109.84M | $109.84M |
| Non-Current Deferred Assets | $26.07M | $22.67M | $23.27M | $27.87M | $27.87M |
| Other Non-Current Assets | $251.63M | $240.75M | $234.98M | $219.22M | $219.22M |
| Total Liabilities | $1.84B | $1.83B | $1.83B | $1.75B | $1.75B |
| Total Current Liabilities | $1.26B | $1.29B | $1.30B | $1.15B | $1.15B |
| Payables | $240.72M | $205.20M | $210.00M | $199.08M | $199.08M |
| -Accounts Payable | $154.09M | $129.10M | $129.97M | $110.41M | $110.41M |
| -Total Tax Payable | $86.64M | $76.10M | $80.03M | $88.67M | $88.67M |
| Current Accrued Expenses | $196.87M | $192.23M | $202.05M | $201.96M | $201.96M |
| Short-Term Debt and Capital Lease Obligation | $575.55M | $695.71M | $706.85M | $500.07M | $500.07M |
| -Current Debt | $549.00M | $669.00M | $680.00M | $473.00M | $473.00M |
| -Current Capital Lease Obligation | $26.56M | $26.72M | $26.85M | $27.07M | $27.07M |
| Current Deferred Liabilities | $40.18M | $36.40M | $36.33M | $35.26M | $35.26M |
| Total Non-Current Liabilities | $573.71M | $542.10M | $529.54M | $596.56M | $596.56M |
| Long Term Accounts Payable and Other Payables | $18.90M | $15.42M | $14.54M | $14.45M | $14.45M |
| Non-Current Accrued Expenses | $63.53M | $41.09M | $39.50M | $42.08M | $42.08M |
| Long Term Debt and Capital Lease Obligation | $397.41M | $400.37M | $398.60M | $475.99M | $475.99M |
| -Long Term Debt | $299.88M | $299.87M | $299.85M | $374.84M | $374.84M |
| -Long Term Capital Lease Obligation | $97.53M | $100.50M | $98.75M | $101.15M | $101.15M |
| Non-Current Deferred Liabilities | $93.88M | $85.22M | $76.91M | $64.04M | $64.04M |
| Total Equity | $1.87B | $1.61B | $1.56B | $1.61B | $1.61B |
| Stockholders' Equity | $1.87B | $1.61B | $1.56B | $1.61B | $1.61B |
| Capital Stock | $10.88M | $10.87M | $10.85M | $10.84M | $10.84M |
| -Common Stock | $10.88M | $10.87M | $10.85M | $10.84M | $10.84M |
| Additional Paid-In Capital | $1.96B | $1.91B | $1.86B | $1.83B | $1.83B |
| Retained Earnings | $7.33B | $7.01B | $6.67B | $6.39B | $6.39B |
| Less: Treasury Stock | -$7.37B | -$7.26B | -$6.93B | -$6.56B | -$6.56B |
| Gains/Losses Not Affecting Retained Earnings | -$60.48M | -$63.54M | -$64.94M | -$68.84M | -$68.84M |
| Other Equity Interests | $5.97M | $5.94M | $6.17M | $6.09M | $6.09M |
| -Accumulated Depreciation | – | – | – | -$925.70M | -$925.70M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $449.72M | $347.16M | $266.25M | $1.18B | $355.76M |
| Net cash flow from continuing operations | $449.72M | $347.16M | $266.25M | $1.18B | $355.76M |
| Net Income from Continuing Operations | $317.15M | $338.41M | $278.45M | $1.06B | $248.19M |
| Depreciation & Depletion & Amortization | $40.56M | $41.05M | $37.68M | $145.18M | $38.72M |
| Deferred Tax | -$1.52M | $6.54M | $13.89M | $131.20M | $31.53M |
| Other Non-Cash Items | -$1.84M | -$319,000.00 | $695,000.00 | $5.03M | $1.78M |
| Change in Working Capital | $77.59M | -$56.94M | -$89.75M | -$227.51M | $16.98M |
| -Change in Receivables | $10.08M | -$26.04M | -$56.81M | -$68.72M | $13.86M |
| -Change in Inventory | $1.66M | -$4.03M | $2.24M | -$789,000.00 | $1.41M |
| -Change in Payables and Accrued Expense | $18.10M | -$6.74M | $11.22M | -$8.57M | -$3.60M |
| -Change In Other Working Capital | $47.75M | -$20.14M | -$46.40M | -$149.43M | $5.30M |
| Net cash flow from investing | -$248.10M | -$25.50M | -$33.54M | -$136.24M | -$28.13M |
| Net Cash Flow from Continuing Investing Activities | -$248.10M | -$25.50M | -$33.54M | -$136.24M | -$28.13M |
| Net PPE Purchase and Sale | -$28.93M | -$24.65M | -$31.98M | -$124.68M | -$29.43M |
| Net Intangibles Purchase and Sale | $0.00 | -$1.89M | -$1.80M | -$13.55M | -$200,000.00 |
| Net Business Purchase and Sale | -$222.63M | $0.00 | -$799,000.00 | -$756,000.00 | -$756,000.00 |
| Net Investment Purchase and Sale | $3.46M | $1.04M | $1.04M | $2.74M | $2.26M |
| Financing Cash Flow | -$200.85M | -$325.19M | -$211.43M | -$1.16B | -$355.70M |
| Net Cash Flow from Continuing Financing Activities | -$200.85M | -$325.19M | -$211.43M | -$1.16B | -$355.70M |
| Net Issuance Payments Of Debt | -$120.00M | -$11.00M | $132.00M | -$30.39M | -$132.00M |
| Net Common Stock Issuance | -$112.17M | -$346.80M | -$351.04M | -$1.22B | -$237.77M |
| Proceeds from Stock Option Exercised | $31.48M | $32.91M | $18.16M | $93.36M | $17.87M |
| Net Other Financing Charges | -$150,000.00 | -$298,000.00 | -$10.56M | -$10.98M | -$3.80M |
| Ending Cash Balance | $197.54M | $196.93M | $200.53M | $180.07M | $180.07M |
| Net Change in Cash | $770,000.00 | -$3.52M | $21.27M | -$119.40M | -$28.07M |
| Beginning Cash Balance | $196.93M | $200.53M | $180.07M | $288.27M | $208.17M |
| Effect of Exchange Rate Changes | -$167,000.00 | -$72,000.00 | -$816,000.00 | $11.20M | -$24,000.00 |
| Free Cash Flow | $420.79M | $320.62M | $232.46M | $1.04B | $326.13M |
No comments yet — be the first to weigh in on IDXX.
Sign in to join the discussion.